New Elemental Impurities Tests for Pharmaceutical Products According to the New ICH Q3D and USP 232/233 Guidelines – Webinar – ResearchAndMarkets.com

The “New
Elemental Impurities Tests for Pharmaceutical Products According to the
New ICH Q3D and USP 232/233 Guidelines” webinar has been added
to ResearchAndMarkets.com’s offering.

This webinar will discuss the new elemental impurities test requirements
as per the new ICH Q3D and USP 232/233 Guidelines, the testing required
to comply with it and how to do proper risk assessment and analytical
measurements, which drug products are within the scope, the
documentation related to control of elemental impurity, which methods
required to be validated.

The objective of this live training webinar is to provide an
understanding of the new standards and guideline, what testing is
required in order to comply with the spirit of the documents, how to
perform a proper risk assessment, and how to perform suitable analytical
measurements.

Areas Covered in the Webinar:

Who Should Attend:

For more information about this webinar visit https://www.researchandmarkets.com/research/h37j5d/new_elemental?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180713005377/en/

Leave a Comment